We are live on
!
Find out more
VanEck Associates Portfolio holdings
AUM
$133B
1-Year Est. Return
72.99%
This Fund
S&P 500
This Quarter
Est. Return
+30.34%
1 Year Est. Return
+72.99%
3 Year Est. Return
+157.94%
5 Year Est. Return
+206.35%
10 Year Est. Return
+770.56%
AUM
$14.8B
AUM Growth
+$2.24B
(+18%)
Cap. Flow
-$211M
Cap. Flow
% of AUM
-1.42%
Top 10 Holdings %
Top 10 Hldgs %
30.47%
Holding
845
New
82
Increased
442
Reduced
285
Closed
30
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
B
Barrick Mining
B
|
+$161M |
| 2 |
Franco-Nevada
FNV
|
+$70.4M |
| 3 |
Harmony Gold Mining
HMY
|
+$61.6M |
| 4 |
Newmont
NEM
|
+$52.8M |
| 5 |
First Majestic Silver
AG
|
+$43.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SLB Ltd
SLB
|
+$84.1M |
| 2 |
AngloGold Ashanti
AU
|
+$63.6M |
| 3 |
SE
Spectra Energy Corp Wi
SE
|
+$41.3M |
| 4 |
Qualcomm
QCOM
|
+$41M |
| 5 |
Walmart Inc
WMT
|
+$40.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Materials | 48.33% |
| 2 | Energy | 21.69% |
| 3 | Healthcare | 7.09% |
| 4 | Industrials | 3.11% |
| 5 | Communication Services | 1.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Sanofi
SNY
$103B
| $12.9M | 0.09% |
322,003
-108,543
| -25% | -$4.36M |
|
152
Pfizer
PFE
$143B
| $12.9M | 0.09% |
459,217
-182,324
| -28% | -$5.21M |
|
153
United Therapeutics
UTHR
$25.8B
| $12.9M | 0.09% |
115,355
-15,141
| -12% | -$1.92M |
|
154
Bristol-Myers Squibb
BMY
$133B
| $12.6M | 0.09% |
197,702
-66,519
| -25% | -$4.19M |
|
|
NVO
155
Novo Nordisk
NVO
$208B
| $12.6M | 0.09% |
465,758
-173,078
| -27% | -$4.64M |
|
|
SHPG
156
DELISTED
Shire pic
SHPG
| $12.6M | 0.08% |
73,307
-9,343
| -11% | -$1.56M |
|
|
MHG
157
DELISTED
Marine Harvest ASA
MHG
| $12.6M | 0.08% |
821,630
-80,383
| -9% | -$1.12M |
|
158
Abbott
ABT
$183B
| $12.4M | 0.08% |
296,886
-65,894
| -18% | -$2.61M |
|
159
Cencora
COR
$60.6B
| $12.2M | 0.08% |
140,438
+3,278
| +2% | +$292K |
|
160
Eli Lilly
LLY
$1.02T
| $11.9M | 0.08% |
165,526
-34,816
| -17% | -$2.63M |
|
161
Toro Company
TTC
$8.75B
| $11.5M | 0.08% |
266,192
-19,802
| -7% | -$761K |
|
|
TSNU
162
DELISTED
Tyson Foods, Inc.
TSNU
| $11.3M | 0.08% |
151,703
+8,453
| +6% | +$570K |
|
163
AstraZeneca
AZN
$263B
| $11.2M | 0.08% |
199,141
-44,620
| -18% | -$2.68M |
|
164
FMC
FMC
$1.34B
| $11.2M | 0.08% |
319,464
-57,007
| -15% | -$1.85M |
|
165
Teva Pharmaceuticals
TEVA
$40.8B
| $11M | 0.07% |
204,714
-44,405
| -18% | -$2.61M |
|
|
166
Walmart Inc
WMT
$885B
| $10.8M | 0.07% |
472,878
-1,848,441
| -80% | -$40.5M |
|
167
Alnylam Pharmaceuticals
ALNY
$27.5B
| $10.8M | 0.07% |
171,879
-21,991
| -11% | -$1.46M |
|
168
Broadcom
AVGO
$1.85T
| $10.2M | 0.07% |
659,180
-76,990
| -10% | -$1.04M |
|
169
Tesla
TSLA
$1.23T
| $10.2M | 0.07% |
663,615
+92,385
| +16% | +$1.22M |
|
|
FTRPR
170
DELISTED
Frontier Communications Corporation 11.125% Series A Mandatory Convertible Preferred Stock
FTRPR
| $10.2M | 0.07% |
97,343
+5,420
| +6% | +$507K |
|
171
Goldgroup Mining Inc.
GORO
$157M
| $10.1M | 0.07% |
4,352,348
+441,838
| +11% | +$794K |
|
172
Texas Instruments
TXN
$252B
| $10.1M | 0.07% |
176,080
-40,562
| -19% | -$2.15M |
|
173
ASML
ASML
$626B
| $9.82M | 0.07% |
97,786
-21,523
| -18% | -$1.94M |
|
174
Sunrun
RUN
$2.34B
| $9.78M | 0.07% |
1,509,046
+105,146
| +7% | +$756K |
|
175
Charles River Laboratories
CRL
$11.2B
| $9.67M | 0.07% |
127,396
+7,389
| +6% | +$547K |
|
Similar funds
VanEck Associates's Q1 2016 Portfolio in Review
As of Q1 2016, VanEck Associates held 845 positions worth $14.8B, up 18% from $12.6B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
VanEck Associates's Q1 2016 filing shows 82 new, 442 increased, 285 reduced and 30 closed positions. Its largest new stake was LinkedIn Corporation: 282,263 shares worth $32.3M. The largest sale was SLB Ltd, an estimated $84.1M.
By sector, the portfolio is most concentrated in Materials at 48% of assets, up from 39% a quarter earlier, followed by Energy and Healthcare.
- VanEck Associates's largest Q1 2016 buy was LinkedIn Corporation: 282,263 shares worth $32.3M.
- VanEck Associates added most to Barrick Mining in Q1 2016, an estimated $161M increase.
- VanEck Associates's biggest Q1 2016 reduction was SLB Ltd, cutting an estimated $84.1M.
- VanEck Associates fully exited IBM in Q1 2016, selling an estimated $35.3M.
- VanEck Associates's ten largest holdings make up 30% of its $14.8B portfolio in Q1 2016.
- VanEck Associates opened 82 new positions and closed 30 in Q1 2016.
- VanEck Associates's portfolio value rose 18% quarter-over-quarter to $14.8B.
Based on VanEck Associates's 13F filing for Q1 2016, filed 13 May 2016.